C linical laboratory automation has been available in the US since 1993. Early automation systems were based on automation models that were developed in Japan and were derived from industrial applications. Justifications for implementing these models were based on improved efficiency and were for the most part significantly subsidized by the Japanese government. In the US, the justification for an automation investment is typically based on a projected ability to reduce labor requirements or to increase capacity to handle more sample volume with fewer FTE's. Early automation models were termed TLA (Total Laboratory Automation), a widely used term with several interpretations. TLA was the only type of automation available at the time, and could be financially justified by a few very large laboratories.
The market for alternatives to TLA was born in response to market requirements for smaller, easier to implement, and less costly automation. New automation system designs that now target specific laboratory tasks (pre-and post-analytical) in a laboratory are being introduced. Roche Diagnostics introduced Task Targeted Automation™ (TTA) in 1998 as a means of providing task specific automation that handles a laboratory's most labor intensive, hazardous and error prone tasks. Task specific automation targets a variety of manual tasks such as sample receipt, sorting, centrifuging, decapping, aliquoting, recapping and archiving. Cost justifying and developing a business case for automation has become easier for more laboratories due to the introduction of new task specific automation systems such as the Roche Diagnostics PSD 1 (Photo 1), Roche VS II (Photo II) along with Roche/Hitachi MODULAR™ PRE-ANALYTICS (Photo III). Laboratory managers now face the new challenge of determining the appropriate amount and type of automation for clinical laboratory verses randomly automating all of a lab's processes. Roche Diagnostics can provide automation solutions from small standalone devices through TLA based on the specific laboratory's Photo 1 Roche Diagnostics PSD 1 requirements. Applying the appropriate level of automation provides several distinct financial benefits that include reduced space requirements, a focused capital investment, a faster payback, and a better return on investment.
Identifying the areas to be targeted for improvement through appropriate levels of automation is the beginning of the process used to cost justify the acquisition of automation. The goals of automation may include reducing the cost of staffing required to handle the laboratory's workload, finding cost efficient ways to allow the laboratory to expand its business, adding new analytical technologies without increasing staff, centralizing testing, improving accuracy in sample handling, improving sample integrity, as well as improving processes in the safe handling of biohazardous materials. Determining the appropriate level of automation for a laboratory involves a comprehensive study of current processes and laboratory organization. Roche Diagnostics offers a Laboratory Process Analysis consultative study that thoroughly analyzes preand post-analytical sample processing and analytical processes in order to identify the location and impact of specific issues affecting the laboratory. The analysis reviews personnel levels, staff competency, financial issues, pre and post analytical processing inefficiencies, physical plant constraints, and the number and configuration of analytical workstations. This analysis assists managers to understand their current operation, and shows how a Roche Diagnostics TTA or TLA solution can be implemented with anticipated results.
In addition to undertaking a review of the current situation, a determination of the short and long-term goals of the laboratory must be made in conjunction with the overall strategy of the entire organization. All available data, processes and procedures must be analyzed to develop cause and effect relationships prior to developing any solutions. The depth and breadth of these studies may point to necessary changes in institutionalized and familiar approaches to doing business. Careful effort must be exerted to minimize the emotional reactions that might result from a perceived intrusion on territorial boundaries. The use of statistical tools and rigorous business analysis is important at this phase to formulate a business case for the decision to invest in process improvements, work station consolidation and automation of specific identified tasks. The goal of the analysis is to identify problem areas and to obtain a systematic, specifically targeted approach to solving the problems. Once the root causes of current problems are identified, a financial analysis of the current operation must be developed to understand the full nature of expenses, revenue and cost allocations and profit drivers. This model will be the basis for comparisons to proforma models based on proposed solutions.
Several financial formulas exist for developing a base case analysis and for comparing different solutions. These must include FTE efficiency, payback periods, and return on investment. Additional tools for analyzing solutions are net present value, internal rate of return, and cash flow analysis. Several commercially available software programs are available to assist in this analysis. The authors have found ProfomIT© available from the CLMA as a valuable tool in performing these analyses.
One of the more commonly cited reasons for automating a laboratory is the desire to reduce FTE's. One should challenge this premise and understand the true underlying goal, which should be to improve profitability or decrease cost through more efficient utilization of FTE's. This mindset creates opportunities for "out of box" planning such as growing workload, introducing new test technologies, implementing quality improvements and increasing capacity in contrast to simply reducing staff.
A better indicator of success is FTE efficiency. The equation for calculating FTE efficiency analyzes the billable tests produced per FTE, and could be used to bench mark an organization to determine the potential impact of any reengineering project ( Table 1 ). An analysis of FTE efficiency before and after automation for each of the proposed automation solutions can help managers compare and contrast the effects of various solutions. Consideration for test complexity should be included to get a valid analysis for FTE efficiency. For instance, fewer tests per FTE can be expected when working with new highly, complex tests (e.g., PCR). Factoring test complexity into the calculation will give you a more complete picture of efficiency improvements.
The analysis of the payback period for a project is another key financial tool that can be used to cost justify the acquisition of automation. The pay back period is defined as the amount of time it will take to recover the capital investment made for a project. This analysis is very useful in evaluating the break-even point for the investment. Capturing all of the tangible financial impacts and risks associated with a proposed project is an important factor in determining total investment cost. A manager will uncover several interesting facts while performing this analysis. A key fact to keep in mind is that a lower system (solution) cost does not necessarily return a more rapid payback. Other factors such as opportunity costs and risk affect total project cost. One example of opportunity cost is committing capital to automating tasks that do not Additionally, it is important that proposed solutions offer a high degree of flexibility and efficiency. For example, can the vender provide systems that directly connect to analyzers to realize additional efficiency improvements? Is the proposed solution more or less efficient in FTE utilization? The answers to these questions will increase or decrease the payback period and must be included as part of a sound financial decision. Typically, over automating, automating with inflexible solutions and assuming too much risk leads to increased payback periods and additional project risk. (Figure I) Return on investment (ROI) is another tool that should be used to compare various solutions. The ROI is the profits (savings) offered by a particular solution compared to investment cost and is typically represented as a percentage. This tool is valuable in comparing various solutions. The greatest return on investment is realized by placing the appropriate levels of automation targeted at maximizing efficiency and minimizing risk by implementing proven technology. A realistic assessment of potential savings is also essential to making a sound business decision and should be based on an accurate projection of the return on investment.
There are currently two general approaches to laboratory automation. These approaches are best described as fixed workcell and flexible solutions. Fixed work cells provide a limited amount of functionality in one non-expandable, non-connectable to analytical analyzers system. A flexible approach applies various components either as stand-alone such as the Roche Diagnostics PSD 1 and VS II or a modular offering such
Fixed Automation Solution
Must automate all processes including efficient processes based on the ability to provide only one type of fixed automation system ROI and payback dependent on vendor discounting system prices, not on applying the appropriate solution to a problem Offers a "one size fits all" approach to providing automation. High volume customers may require multiple units No capability to link automation to analyzers, system expansion means adding additional systems Typically little or no capacity for post analytical processing Offers a variety of solutions to target specific processes after a detailed laboratory analysis is performed to determine appropriately automatable functions Offers the ability to target a payback and ROI based on providing the appropriate level of automation Solutions vary from the medium sized laboratory to the very large volume laboratory using the proper configuration of automation as Roche/Hitachi MODULAR™ PRE-ANALYTICS that is tailored to the required functionality. (Table II) A laboratory must decide which alternative best suits its business plan.
Task Targeted Automation™ (TTA) is a systematic and specifically staged approach to automation. Applying the appropriate level of automation solutions allows managers to custom tailor acquisition of automation hardware against specific goals and requirements, and is easily cost justified based on realistic operational goals and outcomes. Managers should use process analysis and financial analysis to document operational and financial aspects of their business and compare automation solutions using the same analysis. Automation acquisitions are much more complex than analyzer purchases, and generally have impact across the entire laboratory. Applying appropriate levels of automation should always be investigated within the realm of operational improvements gained from workstation consolidation and process integration in order to maximize the effect of a laboratory integration reengineering program. n
